PetMed Express downgraded to Neutral from Buy at Sidoti » 08:4602/2402/24/20
Sidoti analyst Anthony…
Sidoti analyst Anthony Lebiedzinski downgraded PetMed Express (PETS) to Neutral from Buy with an unchanged price target of $31. The shares have rallied 90% since reaching a 52-week low of $15 on July 12, leaving limited upside potential, noted Lebiedzinski. The analyst also noted that competition will remain "fierce," especially from Chewy.com (CHWY).
Chewy initiated with an Outperform at Evercore ISI » 06:2002/2402/24/20
Evercore ISI analyst…
Evercore ISI analyst Oliver Wintermantel initiated coverage of Chewy with an Outperform rating.
Fly Intel: Wall Street's top stories for Friday » 16:1102/2102/21/20
DE, S, TMUS, DTEGY, SFTBY, FSLR, KO, EBAY, CHWY, EGO, DBX, CMCM, GOOG, GOOGL, VAL, APPN
The S&P 500 ended…
Fly Intel: Wall Street's top stories at midday » 12:0002/2102/21/20
DE, S, TMUS, DTEGY, SFTBY, FSLR, CHWY, EGO, DBX, CMCM, VAL, APPN
Stocks have been under…
Fly Intel: Top five analyst upgrades » 10:0202/2102/21/20
REAL, SFM, CHWY, WW, SWAV
Catch up on today's…
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. RealReal (REAL) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler saying he expects continued positive near-term fundamental trends, including strong gross merchandise volume growth and margin improvement. 2. Sprouts Farmers Market (SFM) upgraded to Outperform from Market Perform at Bernstein with analyst Brandon Fletcher saying the recent drop in Sprouts shares seems to rely too heavily on the read-through from Lucky's Market's bankruptcy. 3. Chewy (CHWY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying he sees FY20 as a profitability inflection year for the company and believes that the stock offers "highly favorable" risk-reward given its "strong sustainable fundamentals," including 25% annual revenue growth and "materially" expanding margins. 4. WW (WW) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser saying her proprietary data suggests that this is a good time to buy shares and consensus calling for 5% sales growth in 2020 appears to be modest with her estimated subscriber growth potential of at least 10%. 5. ShockWave Medical (SWAV) upgraded to Buy from Neutral at BofA with analyst Bob Hopkins citing the strong start to the company's below-the-knee launch. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Chewy upgrade, Shake Shack downgrade among today's top analyst calls » 09:5802/2102/21/20
APHA, CGC, HEXO, REAL, WW, DPZ, SHAK, CHWY
Check out today's top…
Unusually active option classes on open February 21st » 09:4002/2102/21/20
MIK, LL, DE, CHWY, WORK, GDX, IYR, MMM, NUGT
Unusual total active…
Unusual total active option classes on open include: Michaels (MIK), Lumber Liquidators (LL), Deere (DE), Chewy (CHWY), Berkshire Hathaway (BRK/B), Slack (WORK), Gold Miners ETF (GDX), iShares DJ US Real Estate Index Fund (IYR), 3M (MMM), and Direxion Daily Gold Miners Bull 3X Shares (NUGT).
Fly Intel: Pre-market Movers » 09:0002/2102/21/20
S, TMUS, CHWY, DE, DBX, SFM, CNK, FSLR, TRUE, ZS, AGRX, BXC
HIGHER: Sprint (S), up 6%…
HIGHER: Sprint (S), up 6% after modifying the T-Mobile (TMUS) combination agreement and announcing the deal could close as early as April 1... Chewy (CHWY), up 4% after RBC Capital analyst Mark Mahaney upgraded shares to Outperform from Sector Perform with an unchanged $38 price target. The analyst sees FY20 as a profitability inflection year for the company and believes that the stock offers a "highly favorable" risk-reward. UP AFTER EARNINGS: Deere (DE), up 6%... Dropbox (DBX), up 15%... Sprouts Farmers Market (SFM), up 9%. DOWN AFTER EARNINGS: Cinemark (CNK), down 5%... First Solar (FSLR), down 10%... TrueCar (TRUE), down 28%... Zscaler (ZS), down 13%. ALSO LOWER: T-Mobile, down 1% after Raymond James analyst Ric Prentiss downgraded the stock to Outperform from Strong Buy with a price target of $107, up from $99... Agile Therapeutics (AGRX), down 13% after its 15M share spot secondary offering priced at $3.00 per share... BlueLinx Holdings (BXC), down 28% after the company responded to a press release issued by an investment firm that goes by the name of Bluefin Acquisitions, which claimed that it was making a tender offer to acquire at least 35% of the company's common stock at a price of $24.50 per share. "The company was not aware of this purported offer," BlueLinx stated in its response last night after the market close.
Chewy upgraded to Outperform from Sector Perform at RBC Capital » 06:1902/2102/21/20
RBC Capital analyst Mark…
RBC Capital analyst Mark Mahaney upgraded Chewy to Outperform from Sector Perform with an unchanged $38 price target. The analyst sees FY20 as a profitability inflection year for the company and believes that the stock offers "highly favorable" risk-reward given its "strong sustainable fundamentals", including 25% annual revenue growth and "materially" expanding margins.
|Over a week ago|
MYOS enters distribution agreement with Chewy » 07:1601/3001/30/20
MYOS (MYOS) announced…
MYOS (MYOS) announced that it has entered into a distribution agreement with Chewy (CHWY). Chewy will distribute MYOS Canine Muscle Formula, an advanced nutrition product that has been clinically shown to increase muscle mass, prevent atrophy of disuse and improve recovery from injuries in canines. This study was conducted at Kansas State University involving 100 dogs.